How to Get Tirzepatide Legally and Safely
Pricing is accurate as of November 2026 and subject to change.
Key Takeaways
- Tirzepatide is prescription-only. The legal ways to get it are FDA-approved Zepbound or Mounjaro, or compounded tirzepatide from a state-licensed pharmacy, always on a prescription from a licensed provider.
- As of November 2026, LillyDirect sells Zepbound vials and KwikPens self-pay for $299 to $449 a month (the $449 tier needs a refill within 45 days). With covered commercial insurance, Lilly's savings card can bring Zepbound pens to $25 through December 31, 2026.
- Eligible Medicare Part D members can get Zepbound for weight management through the Medicare GLP-1 Bridge, with a $50 copay, from July 1, 2026 to December 31, 2027.
- The FDA ended the tirzepatide shortage on December 19, 2024, and the wind-down for compounders ended in March 2025. Now a state-licensed pharmacy may compound it only for an individual patient's prescription, not as regular copies of Zepbound or Mounjaro, and outsourcing facilities may not make it from bulk ingredients.
- Avoid tirzepatide sold without a prescription, labeled "for research use only," shipped from a foreign website, or sold as drops or tablets: the FDA says no oral or sublingual tirzepatide is approved.
- Check your prescriber's license with your state medical board and the pharmacy with your state board of pharmacy (FDA's BeSafeRx page links every state). At MaxLife, compounded tirzepatide is $120/mo flat and is not FDA-approved.

To get tirzepatide legally, you need a prescription from a licensed provider, filled by a state-licensed pharmacy. As of November 2026, there are two kinds of legal tirzepatide: FDA-approved brand products made by Eli Lilly, Zepbound® (weight management and sleep apnea) and Mounjaro® (type 2 diabetes), and compounded tirzepatide, which a state-licensed pharmacy prepares for one patient's prescription. You can reach them through your insurance, Medicare's GLP-1 Bridge, Lilly's LillyDirect pharmacy, a retail pharmacy, or a telehealth or local provider. Tirzepatide sold without a prescription, labeled "for research use only," or shipped from a foreign website is not a legal source, and the FDA urges consumers to buy only from state-licensed pharmacies.
If you're paying cash, one option is compounded tirzepatide at MaxLife: $120/mo flat, prescribed only if a licensed provider decides it's right for you. Compounded tirzepatide is not FDA-approved.
How Do You Get Tirzepatide? 5 Steps
Getting tirzepatide comes down to five steps, whichever product you end up with:
- See a licensed provider, in person or through telehealth. The provider reviews your health history, weight, conditions and medicines, and decides whether tirzepatide is right for you.
- Choose the product with your provider: Zepbound for weight management or sleep apnea, Mounjaro for type 2 diabetes, or compounded tirzepatide if your provider decides it fits your needs.
- Check how you'll pay: insurance, the Medicare GLP-1 Bridge, Lilly's self-pay prices, or a cash-pay compounded program.
- Have the prescription sent to a licensed pharmacy: a retail pharmacy, LillyDirect, or a state-licensed compounding pharmacy that can ship to your state.
- Check the prescriber, the pharmacy and the label before your first dose (the checklist is below).
Do You Need a Prescription for Tirzepatide?
Yes. Tirzepatide is a prescription-only medicine in every form, and there is no legal over-the-counter version. The FDA tells patients to "obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy," and it lists a seller that "does not require a screening and prescription by a licensed doctor" as a red flag (FDA, content current as of October 2026).
To get prescribed tirzepatide, you need a provider who finds it right for you. The Zepbound label covers adults with obesity, or adults with overweight and at least one weight-related condition, such as high blood pressure. Its main trial enrolled people with a BMI of 30 or more, or 27 to under 30 with such a condition. Zepbound is also approved for moderate to severe obstructive sleep apnea in adults with obesity. Mounjaro is approved for type 2 diabetes. The provider also checks reasons not to use it, such as a personal or family history of medullary thyroid cancer or MEN 2, pregnancy, and other GLP-1 medicines you take.
A provider can be your primary care doctor, a specialist, or a telehealth provider licensed in your state. What matters is a real review of your health and a prescription written for you.
What Are the Legal Ways to Get Tirzepatide?
There are two kinds of legal products and a handful of routes to them. Here is the short map:
| Route | What you get | FDA-approved? |
|---|---|---|
| Insurance or Medicare | Zepbound or Mounjaro | Yes |
| LillyDirect self-pay | Zepbound or Mounjaro | Yes |
| Retail pharmacy | Zepbound or Mounjaro | Yes |
| Telehealth or local provider plus a 503A pharmacy | Compounded tirzepatide | No |
Brand Zepbound and Mounjaro are the only FDA-approved tirzepatide products. There is no FDA-approved generic of Zepbound or Mounjaro as of November 2026. Compounded tirzepatide is legal only under the federal compounding rules explained below. The differences between the brand and compounded versions are laid out in our guide to tirzepatide vs Zepbound.
How Do You Get Zepbound or Mounjaro?
You get Zepbound or Mounjaro with a prescription filled at a retail pharmacy, a mail-order pharmacy, or Lilly's own LillyDirect pharmacy. How you pay decides which route is cheapest.
With insurance or Medicare
If your plan covers Zepbound, you pay your plan's copay, and your plan may require prior authorization first. With commercial coverage, Lilly's savings card lets eligible people pay as little as $25 for a 1 to 3 month fill of Zepbound single-dose pens; the card ends on December 31, 2026, and caps savings at $100 a month and $1,300 a year (Lilly terms). People with Medicare or other government coverage can't use the card.
Medicare Part D members may qualify for the Medicare GLP-1 Bridge, a short-term CMS program that runs from July 1, 2026 to December 31, 2027 with a $50 copay for eligible people. Lilly says eligible Part D members with a Zepbound prescription for weight management can get the Zepbound KwikPen through it for no more than $50 a month.
Mounjaro is approved for type 2 diabetes, and coverage depends on your plan. Ask your insurer which tirzepatide products it covers, for which conditions, and what proof it needs.
Without insurance: LillyDirect and retail pharmacies
LillyDirect is Eli Lilly's direct-to-patient pharmacy service. As of November 2026, its self-pay prices for Zepbound vials and KwikPens are $299 a month for the 2.5 mg starting dose, $399 for 5 mg and $449 for 7.5 mg to 15 mg when you refill within 45 days. If you refill later, the higher doses cost $499 (7.5 mg) or $699 (10 mg to 15 mg). Lilly defines a month as 28 days.
A few facts help you plan:
- Vials are sold only through LillyDirect, for self-pay. You can have them delivered free or pick them up at a Walmart Pharmacy.
- The KwikPen holds four weekly doses and is also sold self-pay through LillyDirect, with home delivery or Walmart Pharmacy pickup.
- LillyDirect fills orders through four dispensing pharmacies: Amazon Pharmacy, Fuze Health, Gifthealth and Walmart Pharmacy.
- At a retail pharmacy, people whose commercial plan doesn't cover the KwikPen can use Lilly's self-pay card to pay as low as $299 to $449 a month, depending on the dose.
- Mounjaro self-pay through LillyDirect is $499 a month, whatever the dose.
Your provider sends the prescription to LillyDirect Pharmacy, and a dispensing pharmacy contacts you to confirm details, savings and checkout.
If you don't have a prescriber yet
LillyDirect links to independent telehealth providers for obesity care (five were listed in November 2026) and to an in-person search tool. Lilly says it "does not endorse or recommend these health care providers," and their visit or membership fees don't include the medicine. Compare those fees with the total cost of other routes before you choose.
How Do You Get Compounded Tirzepatide?
You get compounded tirzepatide with a prescription from a licensed provider, filled by a state-licensed compounding pharmacy (a 503A pharmacy) that is licensed to ship to your state. Many people get it through a telehealth program, which connects them with a prescriber and a partner pharmacy; others get it through a local clinic.
Compounded tirzepatide is prepared by a licensed pharmacy for one patient's prescription and is not FDA-approved, which means the FDA hasn't reviewed it for safety, effectiveness or quality. It is not a generic, and it is not covered by insurance. The trial results you read about belong to Zepbound and Mounjaro; these results have not been shown for compounded tirzepatide.
Since the tirzepatide shortage ended, the rules are narrower. According to the FDA's statement updated April 1, 2026, a state-licensed pharmacy may compound tirzepatide for an individual patient's prescription. It may not regularly make copies of Zepbound or Mounjaro unless the prescriber documents a change that "produces a significant difference" for that patient. Outsourcing facilities (503B) may not compound it from bulk tirzepatide, because it is not on their bulks list or on the shortage list. The FDA also says compounded drugs "should only be used in patients whose medical needs cannot be met by an FDA-approved drug." Your prescriber decides whether a compounded product fits you.
For the full legal picture, including state rules, read is compounded tirzepatide still legal in 2026. State-by-state rules and online options are on our tirzepatide providers by state pages.
What Changed After the Tirzepatide Shortage Ended?
The FDA ended the tirzepatide shortage on December 19, 2024, and the wind-down periods for compounding copies ended in March 2025. A federal appeals court upheld the FDA's decision on August 27, 2026. The key dates:
| Date | What happened |
|---|---|
| Dec 15, 2022 | FDA adds tirzepatide injection to its drug shortage list |
| Oct 2, 2024 | FDA says the shortage is resolved; a court case sends the decision back for review |
| Dec 19, 2024 | FDA again decides the shortage is resolved and sets wind-down periods |
| Mar 5, 2025 | A court declines to block FDA; the wind-down for 503A pharmacies ends |
| Mar 19, 2025 | The wind-down for 503B outsourcing facilities ends |
| Feb 6, 2026 | FDA says sellers can't call compounded drugs generic or the same as approved drugs |
| Apr 1, 2026 | FDA restates the conditions for compounding GLP-1 medicines |
| Apr 30, 2026 | FDA proposes keeping tirzepatide off the 503B bulks list (no final decision as of November 2026) |
| Aug 27, 2026 | The Fifth Circuit affirms FDA's shortage decision |
What this means for you: compounded tirzepatide is still available, but only as a prescription for you from a state-licensed pharmacy that follows these rules. The full timeline, with every source, is on our compounded tirzepatide legal status page.
Can You Get Tirzepatide Online?
Yes. You can get a tirzepatide prescription online from a licensed telehealth provider, and the medicine can ship to your home from a licensed pharmacy. That is true for brand Zepbound and Mounjaro and for compounded tirzepatide.
A legitimate online route has the same parts as an office visit. A provider licensed in your state reviews your health history and records, through an online intake, a video visit or both, depending on the program and your state. The prescription goes to a named pharmacy licensed to ship to your state, and a licensed clinician answers your questions after the medicine arrives. Some programs and state rules call for a video visit or lab work; others do not. Ask before you pay.
What you can't legally do online is skip the prescription. A website that ships tirzepatide without a provider's review is not a legal source, whatever it calls the product.
How Do You Check a Prescriber and a Pharmacy?
Check the person who prescribes and the pharmacy that fills it, before you pay:
- Get two names in writing: your prescriber and the pharmacy that will make or fill your medicine. A legitimate program will tell you both.
- Look up the prescriber's license on your state medical board's website. The license should be active in the state where you are during the visit.
- Look up the pharmacy in your state board of pharmacy's database. The FDA's BeSafeRx page links every state's database and says: "If your online pharmacy is not listed, you should not use that pharmacy." An out-of-state pharmacy needs a license or registration in your state.
- Confirm the basics the FDA lists: the pharmacy requires a prescription, gives a U.S. address and phone number, and has a licensed pharmacist to answer questions.
- Know the pharmacy type. A compounded tirzepatide prescription should come from a 503A pharmacy. In 2026, 503B outsourcing facilities may not make it from bulk tirzepatide.
- Check the label when it arrives: the pharmacy's real name and address, your name, the drug and its strength per milliliter, every added ingredient, a discard date and instructions. Compare it with what you were told.
- Check any certification seal. LegitScript certifies pharmacies and telehealth providers, and you can confirm a seal with its public lookup. MaxLife is LegitScript certified.
For more checks, see the six checks and 10 questions in our best tirzepatide providers guide and the pharmacy checklist on our legal status page.
Which Tirzepatide Sources Are Not Legal or Safe?
Any source that skips the prescription, hides the pharmacy, or sells tirzepatide as a "research" chemical is not a legal or safe way to get it. The FDA's own red flags, from its GLP-1 consumer page and its guide to buying medicines safely online, include:
- No prescription or no screening. The FDA calls this a red flag. So is no licensed doctor to answer questions after the medicine arrives.
- "For research use only" or "not for human consumption." The FDA says companies have "illegally sold" tirzepatide labeled this way, often with dosing instructions, and "urges consumers not to purchase these products which are of unknown quality and may be harmful." Sites that sell tirzepatide as a "research peptide" fall in this group.
- Foreign websites. The FDA says that "in most circumstances, it is illegal for individuals to import drugs" for personal use, and that it recommends "only obtaining medicines from legal sources in the U.S." (FDA). Packaging in a foreign language is a warning sign.
- Oral, sublingual or drop "tirzepatide." In a May 2026 notice, the FDA wrote that "no tirzepatide drug product is approved" for oral, under-the-tongue or inside-the-cheek use. Our tirzepatide pill guide explains what is and isn't approved.
- Claims the FDA rejects: a compounded drug called a generic, "the same as" Zepbound or "clinically proven," or a pharmacy called "FDA-approved." The FDA says it "does not approve or license any facility."
- Prices that seem too good to be true, medicine that looks different from what you were shown, damaged packaging, spelling errors on the label, or a pharmacy address that doesn't check out.
- Retatrutide or other unapproved GLP-1s. The FDA says retatrutide "cannot be used in compounding under federal law."
The FDA warns that illegally sold tirzepatide "may be counterfeit" and could contain the wrong ingredient or too much, too little or none of the drug. If you have a problem with any medicine, you can report it to the FDA's MedWatch program.
How Much Does Tirzepatide Cost by Route?
Tirzepatide costs from as little as $25 a month with covered insurance to about $1,087 at list price, as of November 2026. Here are the main routes:
| Route | Monthly cost | Good to know |
|---|---|---|
| Zepbound, commercial coverage plus Lilly's savings card | As little as $25 | Single-dose pens; card ends Dec 31, 2026 |
| Zepbound, Medicare GLP-1 Bridge | $50 copay | Eligible Part D members; through Dec 31, 2027 |
| Zepbound, LillyDirect self-pay | $299 to $449 | $449 tier needs a refill within 45 days |
| Zepbound KwikPen at a pharmacy, plan doesn't cover it | As low as $299 to $449 | With Lilly's self-pay card |
| Mounjaro, LillyDirect self-pay | $499 | Type 2 diabetes |
| Zepbound list price, no program | About $1,087 | Shown on TrumpRx.gov |
| Compounded tirzepatide, online programs | Median $129 over a year | Not FDA-approved; fees vary |
| Compounded tirzepatide, MaxLife | $120/mo flat | All-inclusive; not FDA-approved |
Brand prices are from LillyDirect, Lilly's savings terms, CMS and TrumpRx.gov. The compounded figures come from our compounded tirzepatide price index: across the 21 online programs we could price in November 2026, a year of compounded tirzepatide works out to a median of $129 a month, and paying one month at a time runs from $126 to about $367 a month. Many low monthly figures require several months paid up front, and some programs add a membership fee or charge more at higher doses. Our guide to the cheapest tirzepatide online compares named programs, fees included.
Which Route Is Right for You?
The right route depends on your coverage, your diagnosis and whether FDA approval matters to you. Talk it through with your provider:
- Your insurance covers Zepbound: this is usually the cheapest route, especially with Lilly's $25 savings card while it lasts.
- You have Medicare Part D: ask about the Medicare GLP-1 Bridge and its $50 copay.
- You have type 2 diabetes: Mounjaro is the tirzepatide product approved to treat it; ask your plan about coverage.
- You pay cash and want an FDA-approved product: LillyDirect's self-pay vials or KwikPen, $299 to $449 a month.
- You pay cash and your provider decides compounded tirzepatide fits you: compare total monthly cost, including any membership fee, months paid up front and dose-based pricing, and check the pharmacy.
How Does MaxLife Fit In?
MaxLife is a telehealth patient management platform for people paying cash, not a pharmacy, drug maker or compounder. You complete an online intake in about 2 minutes. A licensed provider reviews your online intake, health history and clinical records, usually within 24 hours, can follow up with questions, and you can ask for a video visit. If the provider decides compounded tirzepatide is right for you, licensed partner pharmacies prepare and dispense it, including Dirx Pharmacy, Southend Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Advanced Pharmacy, Perfect Rx Pharmacy, Health Wealth Pharmacy, Quaker Community Pharmacy, VLS Pharmacy and NewLife Rx Pharmacy.
Compounded tirzepatide at MaxLife is $120/mo flat: all-inclusive, with the provider's review and follow-up, the medicine if prescribed, supplies and free expedited shipping. It is the same price at every dose, with no membership fee and no hidden fees. No insurance is needed, HSA and FSA funds may be eligible, and you can cancel anytime with notice before your next billing period. MaxLife serves all 50 states, has a Spanish-speaking team and is LegitScript certified. It sells no pills or oral forms.
Be clear about the trade: compounded tirzepatide at MaxLife costs less than self-pay Zepbound, but it is not FDA-approved and insurance doesn't cover it. If your insurance covers Zepbound, that route may cost you less. To compare MaxLife with other online programs on real cost, see our best tirzepatide providers guide.
The Bottom Line
You can get tirzepatide legally in one way only: with a prescription from a licensed provider, filled by a state-licensed pharmacy. Brand Zepbound and Mounjaro come through insurance, the Medicare GLP-1 Bridge, LillyDirect or a retail pharmacy. Compounded tirzepatide comes from a 503A pharmacy on your prescription, usually through telehealth, and is not FDA-approved. Check the prescriber and the pharmacy, and walk away from any seller that skips the prescription, sells "research" vials or ships from abroad. At MaxLife, compounded tirzepatide is $120/mo flat, and a licensed provider decides whether it's right for you.
Frequently Asked Questions
Compounded Tirzepatide: $120/mo Flat, All-Inclusive
MaxLife compounded tirzepatide: $120 a month, flat. All-inclusive, no membership fee, the same price at every dose. A licensed provider decides.
Check Your EligibilityThis article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary. Pricing, insurance coverage, and compounding regulations described here are subject to change; verify current details with your insurance provider, the manufacturer, or your prescriber before making treatment decisions. Compounded medications are not FDA-approved.
Why trust our experts

April Foster, DO MPH
Reviewer
Board Certified Family Medicine Physician licensed nationwide providing collaborative oversight to NPs, PAs, and RN. Also specializing in telemedicine services nationwide.
Sources
- FDA: FDA's concerns with unapproved GLP-1 drugs used for weight loss (content current as of October 1, 2026)
- FDA: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (updated April 1, 2026)
- FDA declaratory order on the tirzepatide injection shortage, December 19, 2024
- U.S. Court of Appeals for the Fifth Circuit, Outsourcing Facilities Association v. FDA, No. 25-10600 (August 27, 2026)
- FDA: FDA proposes to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
- Federal Register 2026-08552: List of bulk drug substances for which there is a clinical need under section 503B (May 1, 2026)
- FDA statement: FDA intends to take action against non-FDA-approved GLP-1 drugs (February 6, 2026)
- FDA: FDA to telehealth companies, what to know when promoting compounded drugs
- FDA BeSafeRx: Locate a state-licensed online pharmacy
- FDA: How to buy medicines safely from an online pharmacy
- FDA: Personal importation
- Zepbound (tirzepatide) prescribing information, DailyMed
- Mounjaro (tirzepatide) prescribing information, DailyMed
- LillyDirect: Zepbound self-pay prices and how to get started
- LillyDirect: Mounjaro self-pay price and dispensing pharmacies
- LillyDirect: telehealth care options
- Zepbound coverage and savings, terms and conditions (Lilly)
- CMS: Medicare GLP-1 Bridge
- TrumpRx.gov: Zepbound vial
- LegitScript: healthcare certification for pharmacies and telemedicine providers

Tirzepatide vs Zepbound: Brand and Compounded Explained
November 5, 202610 min

Tirzepatide Cost: Price Per Month With and Without Insurance
August 20, 202614 min

Is There a Tirzepatide Pill? Foundayo and Oral Options
November 7, 202611 min

Weight Loss Drugs Covered by Insurance: What to Know
August 20, 202614 min
